Evidence map›Paper›PMID 31792342›Full record

ArticleScientific reports2019

Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosa.

Gökçe Günaydın, Gabriella Edfeldt, David A Garber, Muhammad Asghar, Laura Noȅl-Romas, Adam Burgener, Carolina Wählby, Lin Wang, Lisa C Rohan, Patricia Guenthner and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. An engineered antibody-lectin conjugate targeting the HIV glycan shield protects humanized mice against HIV challenge.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  2. Article
  3. Article
  4. ACS chemical biology · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin.Frontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Gökçe GünaydınDepartment of Medicine Solna, Division of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Gabriella EdfeldtDepartment of Medicine Solna, Division of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
David A GarberLaboratory Branch, Division of HIV/AIDS Prevention, National Centre for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease and Tuberculosis Prevention, CDC, Atlanta, USA.ORCID http://orcid.org/0000-0003-3608-7104
Muhammad AsgharDepartment of Medicine Solna, Division of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Laura Noȅl-RomasNational HIV and Retrovirology Labs, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Canada.
Adam BurgenerDepartment of Medicine Solna, Division of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Carolina WählbyDepartment of Information Technology, Centre for Image Analysis, Uppsala University, Science for Life Laboratory, Uppsala, Sweden.
Lin WangMagee-Womens Research Institute, Pittsburgh, USA.
Lisa C RohanMagee-Womens Research Institute, Pittsburgh, USA.
Patricia GuenthnerLaboratory Branch, Division of HIV/AIDS Prevention, National Centre for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease and Tuberculosis Prevention, CDC, Atlanta, USA.
James MitchellLaboratory Branch, Division of HIV/AIDS Prevention, National Centre for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease and Tuberculosis Prevention, CDC, Atlanta, USA.
Nobuyuki MatobaCenter for Predictive Medicine, University of Louisville, Louisville, USA.
Janet M McNichollLaboratory Branch, Division of HIV/AIDS Prevention, National Centre for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease and Tuberculosis Prevention, CDC, Atlanta, USA.
Kenneth E PalmerCenter for Predictive Medicine, University of Louisville, Louisville, USA.
Annelie TjernlundDepartment of Medicine Solna, Division of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. annelie.tjernlund@ki.se.
Kristina BrolidenDepartment of Medicine Solna, Division of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Karolinska University Hospital · SENational Center for HIV/AIDS Viral Hepatitis STD and TB Prevention · USUniversity of Louisville · USMagee-Womens Research Institute · USPublic Health Agency of Canada · CAUniversity of Pittsburgh · USUppsala University · SE

Funding

Project 3: PREVENT: A first-in-human clinical trial of Griffithsin, an HIV entryU19AI113182 · NIAID · UNIVERSITY OF LOUISVILLE · PI BRAND, RHONDA METTER · 2014 to 2018
$14.8M
NIAID NIH HHS U19 AI113182
6 · The paper itself

Abstract

Natural-product derived lectins can function as potent viral inhibitors with minimal toxicity as shown in vitro and in small animal models. We here assessed the effect of rectal application of an anti-HIV lectin-based microbicide Q-Griffithsin (Q-GRFT) in rectal tissue samples from rhesus macaques. E-cadherin

Indexed as

AnimalsAnti-HIV AgentsAnti-Infective Agents, LocalCadherinsCD4 AntigensCell CountEpithelial CellsIntestinal MucosaLectinsMacaca mulattaPlant LectinsRecombinant ProteinsRectumTime FactorsAnti-HIV AgentsAnti-Infective Agents, LocalCadherinsCD4 Antigensgriffithsin protein, GriffithsiaLectinsPlant Lectinsq-griffithsinRecombinant Proteins

Identifiers

PMID31792342
PMCPMC6889265
OpenAlexW2990918333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.